AMGN Summary

  1. NASDAQ
  2. >
  3. AMGN
TickerAMGN
DescriptionAMGEN INC
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology. Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.
ExchangeNASDAQ
TypeStock
SectorHealthcare
Employees24,300
Next Earnings DateNovember 1st, 2022
Ex-Dividend DateAugust 17th, 2022
Yield3.07827%
Dividend$1.94
IV18.614553%
IV Percentile3rd
IV Rank6.27%
IV Skew-6.906246
IV Skew Percentile4th
IV Skew SentimentBullish
Option Volume3,520
Volume3,461,117
Price$248.41
Previous Close$248.35
52-Week High$258.45
52-Week Low$198.64
50-Day Moving Avg.$246.95
200-Day Moving Avg.$239.13
10-Day Avg. Volume2,513,957
20-Day Avg. Volume2,437,728
30-Day Avg. Volume2,459,091
3-Month Avg. Volume3,159,113
PE24.88549
EPS$10.13
Outstanding Shares534,930,850
Market Capitalization$134,666,461,099
CurrencyUSD
UpdatedAugust 12th, 2022